Brain Research Bulletin - Mar 21, 2026
Back to Stakeholders
Categories
1 domain / 2 areas / 1 specialization
University of Zurich
Data updated
Switzerland
8 Trials1 Paper
Within the 'Department of Psychiatry, Psychotherapy and Psychosomatics' at the University of Zurich, Dr Milan Scheidegger is leading a team conducting psychedelic research and therapy development. Researchers here are investigating the therapeutic potential of psychedelics to reverse maladaptive neurobehavioral patterns in stress-related mood disorders and to enhance psychotherapeutic learning capabilities.
Academic Research
1 papersPublished Papers
1
Trial Involvement
8
Distinct Focus Topics
0
Latest Publication
Mar 21, 2026
Recent Papers
Quick Facts
- Type
- academic
- HQ
- Switzerland
- Website
- Visit
Research Landscape
What the 8 registered trials University of Zurich sponsors or participates in look like when you line them up. Counts come from Blossom’s trial records as of July 2026.
What's live right now, and what stopped?
SourcedRegistry status of all 8 University of Zurich trials Blossom tracks. Orange marks trials recruiting or opening.
Don't read stopped trials as failures: trials end early for funding, recruitment, and strategy reasons too. Status is as last synced from the registry; some 'recruiting' trials may already have finished.